Literature DB >> 12632377

Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy.

KuoJen Tsao1, Samuel Hawgood, Lan Vu, Shinjiro Hirose, Roman Sydorak, Craig T Albanese, Diana L Farmer, Michael R Harrison, Hanmin Lee.   

Abstract

BACKGROUND/
PURPOSE: Development of hydrops fetalis in fetuses with congenital cystic adenomatoid malformations (CCAM) is a significant risk factor for fetal or neonatal demise. In rare cases, resolution of CCAM has occurred, presumably owing to lesion maturation or involution. Steroid therapy, utilized for lung maturity, has been postulated to accelerate this process. The natural history of hydropic fetuses with CCAM after receiving steroid therapy is presented.
METHODS: The authors prospectively followed up with 3 patients who had antenatally diagnosed CCAM and nonimmune hydrops fetalis with predicted mortality. All patients declined or were not candidates for fetal intervention and were treated with standard prenatal betamethasone to increase lung maturity.
RESULTS: Three fetuses had CCAM and nonimmune hydrops fetalis diagnosed prenatally. After a course of prenatal steroids during the second trimester, all 3 patients had resolution of their hydrops and were delivered at term without respiratory distress.
CONCLUSIONS: Nonimmune hydrops fetalis in fetuses with congenital cystic adenomatoid malformation is a harbinger for fetal demise. The resolution of hydrops in these patients after receiving steroid therapy is an interesting and compelling observation. Because the mechanism of this process is speculative, further studies are needed to elucidate the relationship between antenatal steroids and maturation of congenital cystic adenomatoid malformation. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12632377     DOI: 10.1053/jpsu.2003.50089

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

Review 1.  Prenatal pharmacotherapy for fetal anomalies: a 2011 update.

Authors:  Lisa Hui; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2011-06-03       Impact factor: 3.050

2.  Obstetrician patterns of steroid administration for the prenatal management of congenital pulmonary airway malformations.

Authors:  Khyzer B Aziz; Angie C Jelin; Amaris M Keiser; Jay Schulkin; Eric B Jelin
Journal:  J Neonatal Perinatal Med       Date:  2021

Review 3.  Thoracoscopic Lobectomy for Congenital Lung Lesions.

Authors:  Jarrett Moyer; Hanmin Lee; Lan Vu
Journal:  Clin Perinatol       Date:  2017-09-28       Impact factor: 3.430

Review 4.  Rare Lung Diseases: Congenital Malformations.

Authors:  Andrew Bush
Journal:  Indian J Pediatr       Date:  2015-06-23       Impact factor: 1.967

Review 5.  Antenatal management of pulmonary hyperplasia (congenital cystic adenomatoid malformation).

Authors:  D Ankers; N Sajjad; P Green; J L McPartland
Journal:  BMJ Case Rep       Date:  2010-07-21

6.  Congenital cystic lesions of the lung: congenital cystic adenomatoid malformation and bronchopulmonary sequestration.

Authors:  Anna K Sfakianaki; Joshua A Copel
Journal:  Rev Obstet Gynecol       Date:  2012

Review 7.  Congenital cystic lung disease: contemporary antenatal and postnatal management.

Authors:  Richard G Azizkhan; Timothy M Crombleholme
Journal:  Pediatr Surg Int       Date:  2008-04-05       Impact factor: 1.827

Review 8.  Fetal counselling for congenital malformations.

Authors:  Kokila Lakhoo
Journal:  Pediatr Surg Int       Date:  2007-03-14       Impact factor: 2.003

Review 9.  Narrative review of congenital lung lesions.

Authors:  Shaun M Kunisaki
Journal:  Transl Pediatr       Date:  2021-05

10.  An unusual prenatal manifestation of a huge congenital cystic adenomatoid malformation with favorable perinatal outcome.

Authors:  Hye-Jin Suk; Hye-Sung Won; Eun Jung Lee; Mi-Young Lee
Journal:  Obstet Gynecol Sci       Date:  2014-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.